‘I felt so empowered, respected and shame free.’ Let’s test for HPV participants’ experience of HPV primary screening
Sally B. Rose
1 * , Lynn McBain 1 , Susan M. Garrett 1 , Rebecca Bell 2 , Carrie Innes 2 , Sarah Te Whaiti 2 , Alexandria Tino 2 , Peter Sykes 2
1
2
Abstract
Aotearoa New Zealand’s National Screening Unit (NSU) moved to use of human papillomavirus (HPV) primary screening in November 2023.
This study aimed to evaluate participants’ views on favourable and unfavourable elements of HPV primary screening and to seek suggestions for potential improvements.
Primary care participants in a multi-region HPV primary screening implementation study were invited to complete an online follow-up survey in September 2023. This paper reports on qualitatively analysed responses to open-ended questions asking participants what they liked, disliked or thought could be improved for future screening participants.
Of 2361 invitations sent, 2302 were delivered, 969 people consented to participate and 921 were included in analyses (40%, 921/2302). Respondents were 24–71 years of age, from three regions, different ethnic groups and included under-screened participants. Most had chosen to self-test (92%) and 28.9% self-tested at home. Three quarters shared comments about what they liked, with themes related to ability to self-test, avoiding cervical tests, choice, communication and support. Twenty percent described unfavourable aspects, with themes related to inadequate information, self-testing issues, inappropriate physical space and process and programme-related factors. Seven key recommendations were identified from suggestions about potential improvements for future screening participants.
Survey participants’ experience of HPV primary screening was overwhelmingly positive, with choice of a self-test a clear benefit for most. Inadequate information or communication contributed to suboptimal experiences for some. Participant recommendations highlight practical steps screen-takers (and the NSU) could take to ensure screening participants receive a well-informed, affirming experience that supports ongoing participation in cervical screening.
Keywords: cervical cancer, cervical screening, human papillomavirus (HPV), patient experience, qualitative, self-sampling, self-test, survey.
References
1 World Health Organization. Eliminating cervical cancer. 2022. Available at https://www.who.int/health-topics/cervical-cancer#tab=tab_2 [accessed 28 May 2024].
2 Te Whatu Ora – Health New Zealand. Historical cancer data, Cancer: Historical summary 1948–2020. Wellington: Te Whatu Ora – Health New Zealand; 2023. Available at https://www.tewhatuora.govt.nz/our-health-system/data-and-statistics/historical-cancer/#cancer-historical-summary-19482020 [accessed 28 May 2024].
3 Best Practice Advocacy Centre New Zealand (BPAC NZ). Cervical smears – achieving equity. 2009. Available at https://bpac.org.nz/bpj/2009/september/docs/bpj23_csmears_pages46-55.pdf [accessed 1 May 2024].
4 Bartholomew K, Lawton B, Sherman SM, et al. Recommendations for implementing HPV self-testing in Aotearoa. N Z Med J 2021; 134(1535): 11-6.
| Google Scholar | PubMed |
5 Te Whatu Ora – Health New Zealand. National Cervical Screening Programme and HPV Primary Screening. Coverage and PHO reports. Wellington: Te Whatu Ora – Health New Zealand. Available at https://tewhatuora.shinyapps.io/nsu-ncsp-coverage/ [accessed 20 September 2024].
6 Costa S, Verberckmoes B, Castle PE, et al. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. Br J Cancer 2023; 128(5): 805-13.
| Crossref | Google Scholar | PubMed |
7 Koliopoulos G, Nyaga VN, Santesso N, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev [8] 2017; CD008587.
| Crossref | Google Scholar | PubMed |
8 Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol 2020; 40(5): 602-8.
| Crossref | Google Scholar | PubMed |
9 Arbyn M, Smith SB, Temin S, et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ 2018; 363: k4823.
| Crossref | Google Scholar | PubMed |
10 Nelson EJ, Maynard BR, Loux T, et al. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect 2017; 93(1): 56-61.
| Crossref | Google Scholar | PubMed |
11 Nishimura H, Yeh PT, Oguntade H, et al. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Glob Health 2021; 6(5): e003743.
| Crossref | Google Scholar | PubMed |
12 Creagh NS, Zammit C, Brotherton JM, et al. The experience of under-screened and never-screened participants using clinician-supported self-collection cervical screening within the Australian National Cervical Screening Program. Womens Health 2022; 18: 17455065221075905.
| Crossref | Google Scholar | PubMed |
13 Adcock A, Stevenson K, Cram F, et al. He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Māori women talk about HPV self-testing cervical screening clinical pathways. Int J Gynecol Obstet 2021; 155(2): 275-81.
| Crossref | Google Scholar |
14 Sultana F, Mullins R, English DR, et al. Women’s experience with home-based self-sampling for human papillomavirus testing. BMC Cancer 2015; 15: 849.
| Crossref | Google Scholar | PubMed |
15 Sherman SM, Brewer N, Bartholomew K, et al. Human papillomavirus self-testing among unscreened and under-screened Māori, Pasifika and Asian women in Aotearoa New Zealand: A preference survey among responders and interviews with clinical-trial nonresponders. Health Expect 2022; 25(6): 2914-23.
| Crossref | Google Scholar | PubMed |
16 MacDonald EJ, Geller S, Sibanda N, et al. Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial. Aust NZ J Obstet Gynaecol 2021; 61(1): 135-41.
| Crossref | Google Scholar |
17 Brewer N, Bartholomew K, Grant J, et al. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand. Lancet Reg Health West Pac 2021; 16: 100265.
| Crossref | Google Scholar | PubMed |
18 Serrano B, Ibáñez R, Robles C, et al. Worldwide use of HPV self-sampling for cervical cancer screening. Prev Med 2022; 154: 106900.
| Crossref | Google Scholar |
19 Borchowsky K, Rush M, Mullally T, et al. Primary care experiences in the ‘Let’s test for HPV’ study: a qualitative analysis. J Prim Health Care 2023; 15(2): 147-54.
| Crossref | Google Scholar | PubMed |
20 Bromhead C, Wihongi H, Sherman SM, et al. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study. Int J Environ Res Public Health 2021; 18(19): 10050.
| Crossref | Google Scholar | PubMed |
21 O’Connor M, Costello L, Murphy J, et al. ‘I don’t care whether it’s HPV or ABC, I just want to know if I have cancer.’ Factors influencing women’s emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study. BJOG 2014; 121(11): 1421-9.
| Crossref | Google Scholar | PubMed |
22 Tiro JA, Betts AC, Kimbel K, et al. Understanding Patients’ Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result. J Womens Health 2019; 28(3): 384-92.
| Crossref | Google Scholar | PubMed |
23 Dodd RH, Mac OA, McCaffery KJ. Women’s experiences of the renewed National Cervical Screening Program in Australia 12 months following implementation: a qualitative study. BMJ Open 2020; 10(7): e039041.
| Crossref | Google Scholar | PubMed |
24 McBride E, Tatar O, Rosberger Z, et al. Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis. Health Psychol Rev 2021; 15(3): 395-429.
| Crossref | Google Scholar | PubMed |
25 Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3(2): 77-101.
| Crossref | Google Scholar |
26 Zelli J, Hum S, Lofters A, et al. Clinician acceptability of self-collected human papillomavirus swabs as a primary cervical cancer screening method. Can Fam Physician 2022; 68(2): e31-8.
| Crossref | Google Scholar | PubMed |
27 Mao C, Kulasingam SL, Whitham HK, et al. Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening. J Womens Health (2002) 2017; 26(6): 609-15.
| Crossref | Google Scholar | PubMed |
28 Styffe C, Tratt E, Macdonald ME, et al. HPV Self-sampling in Indigenous Communities: A Scoping Review. J Immigr Minor Health 2020; 22(4): 852-9.
| Crossref | Google Scholar | PubMed |
29 Obermair HM, Dodd RH, Bonner C, et al. It has saved thousands of lives, so why change it?’ Content analysis of objections to cervical screening programme changes in Australia. BMJ Open 2018; 8(2): e019171.
| Crossref | Google Scholar | PubMed |
30 Smith LW, Racey CS, Gondara L, et al. Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results. BMJ Open 2021; 11(10): e052084.
| Crossref | Google Scholar | PubMed |
31 Tatar O, Thompson E, Naz A, et al. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis. Prev Med 2018; 116: 40-50.
| Crossref | Google Scholar |
32 Chorley AJ, Marlow LA, Forster AS, et al. Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis. Psychooncology 2017; 26(2): 161-72.
| Crossref | Google Scholar | PubMed |
33 Wearn A, Shepherd L. Determinants of routine cervical screening participation in underserved women: a qualitative systematic review. Psychol Health 2024; 39(2): 145-70.
| Crossref | Google Scholar | PubMed |
34 Te Whatu Ora Health New Zealand. National Cervical Screening Programme and HPV Primary Screening. Learning resources. 2023. Available at https://www.tewhatuora.govt.nz/health-services-and-programmes/ncsp-hpv-screening/learning-resources/ [accessed 29 August 2024].
35 Te Whatu Ora Health New Zealand Health Information and Services. Cervical screening. 2024. Available at https://info.health.nz/keeping-healthy/cancer-screening/cervical-screening [accessed 29 August 2024].
36 HealthEd. Cervical screening resources. 2023. Available at https://healthed.govt.nz/collections/topic-cervical-screening [accessed 29 August 2024].
37 Te Whatu Ora Health New Zealand National Cervical Screening Programme. Provider toolkit, A guide to using the HPV Cervical Screening Māori and all Aotearoa campaign resources. 2023. Available at https://www.tewhatuora.govt.nz/assets/For-the-health-sector/NSU/For-Health-professionals/Cervical-Screening-Programme/Maori-and-All-Aotearoa-Campaign-Provider-toolkit-3_5-October-2023.pdf [accessed 29 August 2024].
